obesity drug news today glp-1 september 29 2025 President Trump announced that Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for weight management indications for people with obesity. Our senior staff writer Kristen Monaco Obesity GLP-1 Market Size to

Tirzepatide, sold as Mounjaro, is a different molecule from Eli Lilly and is not part of this Semaglutide patent expiry story

Reshipment: Replacement for lost/damaged items (3-5 business days)

A systematic review and meta-analysis by Lee et al

This age-related decline is significant

Notably, EV-associated DAMPs have been found in stored red blood concentrates [238], suggesting that eryptosis-mediated generation of EVs might exert immunomodulatory DAMP-triggered effects

Diabetic complications, pancreatic inflammation, and severe heart muscle weakness: In a 56-year-old woman with a complex medical history and whose outpatient medication had not been adjusted in the last 3 years